EcoDrugPlus

Protein Kinase C Theta

Ensembl ID : ENSCHYG00000020588
Gene Symbol: PRKCQ
1 Cross references
204 Possible Orthologues:

Protein Kinase C Zeta

Ensembl ID : ENSCHYG00000026939
Gene Symbol: PRKCZ
1 Cross references
201 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSCHYG00000006534
Gene Symbol: PRKD3
1 Cross references
274 Possible Orthologues:

Protein Kinase Camp-Activated Catalytic Subunit Alpha

Ensembl ID : ENSCHYG00000007558
Gene Symbol: PRKACA
1 Cross references
288 Possible Orthologues:

Protein Kinase Camp-Activated Catalytic Subunit Beta

Ensembl ID : ENSCHYG00000022683
Gene Symbol: PRKACB
1 Cross references
304 Possible Orthologues:

Protein Kinase, Dna-Activated, Catalytic Subunit

Ensembl ID : ENSCHYG00000016168
Gene Symbol: PRKDC
1 Cross references
187 Possible Orthologues:

Protein Phosphatase 3 Catalytic Subunit Alpha

Ensembl ID : ENSCHYG00000007442
Gene Symbol: PPP3CA
1 Cross references
232 Possible Orthologues:

Protein Tyrosine Kinase 2

Ensembl ID : ENSCHYG00000017386
Gene Symbol: PTK2
1 Cross references
233 Possible Orthologues:

Protein Tyrosine Kinase 2 Beta

Ensembl ID : ENSCHYG00000005281
Gene Symbol: PTK2B
1 Cross references
213 Possible Orthologues:

Protein Tyrosine Kinase 6

Ensembl ID : ENSCHYG00000022722
Gene Symbol: PTK6
1 Cross references
174 Possible Orthologues:

Protein Tyrosine Phosphatase Non-Receptor Type 11

Ensembl ID : ENSCHYG00000004010
Gene Symbol: PTPN11
1 Cross references
253 Possible Orthologues:

Protein Tyrosine Phosphatase Receptor Type B

Ensembl ID : ENSCHYG00000000385
Gene Symbol: PTPRB
1 Cross references
268 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).